Maravai LifeSciences Holdings Inc - Ordinary Shares - Class A

+0.36 (+1.64%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)2.89B
Current PE5.13
Forward PE 12.47
2yr Forward PE 25.23
See more stats
Estimates Current Quarter
Revenue$195.46 Million
Adjusted EPS$0.33
See more estimates
10-Day MA$23.81
50-Day MA$24.23
200-Day MA$30.46
See more pivots

Maravai LifeSciences Holdings Inc - Ordinary Shares - Class A Stock, NASDAQ:MRVI

10770 Wateridge Circle, Suite 200, San Diego, California 92121
United States of America
Phone: +1.858.546.0004
Number of Employees: 470


Maravai Lifesciences Holdings, Inc. is a life sciences company. It is engaged in providing products to enable the development of drug therapies, diagnostics, and novel vaccines and to support research on human diseases. The firm operates through the following segments: Nucleic Acid Production, Biologics Safety Testing, and Protein Detection. The Nucleic Acid Production segment focuses on the manufacturing and sale of highly modified nucleic acids products to support the needs of customersâ?? research, therapeutic and vaccine programs. The Biologics Safety Testing segment focuses on manufacturing and selling biologics safety and impurity tests and assay development services that are utilized by its customers in their biologic drug manufacturing activities. The Protein Detection segment is engaged in manufacturing and selling labeling and visual detection reagents to scientific research customers for their tissue-based protein detection and characterization needs. The company was founded by Eric Tardif and Carl W. Hull in March 2014 and is headquartered in San Diego, CA.